This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Vulvovaginal Atrophy
and you are
over 35
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

This is an open-label extension study evaluating the long-term safety and efficacy of WC3011 in non-hysterectomized, healthy, postmenopausal women with vulvovaginal atrophy.

Provided treatments

  • Drug: Estradiol Vaginal Gel

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01455597. The sponsor of the trial is Warner Chilcott and it is looking for 309 volunteers for the current phase.
Official trial title:
A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of WC3011 in the Treatment of Symptoms of Vulvovaginal Atrophy in Postmenopausal Women